Doença Renal Policística: Diretrizes Médicas (Crônica (Polycistic Kidney Disease: Guidelines)

■ An update on the use of tolvaptan for autossomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network andd Polycystic Kidney Disease International

Roman-Ulrich Müller, A Lianne Messchendorp, Henrik Birn et al

Nephrol Dial Transplant. 2022 May; 37(5): 825–839.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035348/

■ Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report

Patrizia Natale, Ronald D Perrone, Allison Tong et al

Clin Kidney J. 2022 Mar; 15(3): 407–416

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862067/

■ International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people

C Gimpel, C Bergmann, D Bockenhauer et al

Nature Reviews Nephrology 2019, vol 15: 713-726

https://www.nature.com/articles/s41581-019-0155-2

■ Doença Renal Policística (Polycystic Kidney Disease)